BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹711 Cr | ₹644 Cr | ₹653 Cr | ₹504 Cr | ₹544 Cr |
What is the latest Net Current Assets ratio of BLISS GVS PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹711 Cr |
| Mar2025 | ₹644 Cr |
| Mar2024 | ₹653 Cr |
| Mar2023 | ₹504 Cr |
| Mar2022 | ₹544 Cr |
How is Net Current Assets of BLISS GVS PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹711 Cr | 10.29 | |
| Mar2025 | ₹644 Cr | -1.37 | |
| Mar2024 | ₹653 Cr | 29.63 | |
| Mar2023 | ₹504 Cr | -7.29 | |
| Mar2022 | ₹544 Cr | - | |
Compare Net Current Assets of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹5,242.0 Cr | 5.6% | -3.1% | 174.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,115.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 5.6% |
-3.1% |
174.4% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses